Tag: Lilly India
Lilly’s Donanemab gets CDSCO approval
Eli Lilly and Company has announced that the Central Drugs Standard Control Organization (CDSCO) has granted marketing authorization for donanemab (350 mg/20 mL administered...
Lilly launches Mounjaro for obesity and type 2 diabetes
Eli Lilly and Company (India) have announced the launch of Mounjaro in single-dose vial presentation following the marketing authorization from the Central Drugs Standard...
Eli Lilly & Cipla enter into a strategic partnership in India
Eli Lilly and Company (India) (hereinafter referred as “Lilly”), headquartered in Gurgaon, is a wholly-owned subsidiary of Eli Lilly and Company, a global biopharmaceutical...